Racial disparities in survival trends in patients with metastatic Hormone receptor positive/Her 2 negative breast cancer: a SEER population-based study

被引：0
|
作者：
Soto, Alvaro Alvarez
Bernal, Ana Maria
Mesias, Jesus Anampa
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P4-03-21
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-03-21
引用
收藏
页数：2
相关论文
共 50 条
  • [41] New insights into patterns of first metastatic sites influencing survival of patients with hormone receptor-positive, HER2-negative breast cancer: a multicenter study of 271 patients
    Jun Yamamura
    Shunji Kamigaki
    Junya Fujita
    Hiroki Osato
    Hironobu Manabe
    Yumiko Tanaka
    Wataru Shinzaki
    Yukihiko Hashimoto
    Yoshifumi Komoike
    BMC Cancer, 21
  • [42] Overall Survival for HER2-Positive Breast Cancer Patients in the HER2-Targeted Era: Evidence From a Population-Based Study
    Marczyk, Vicente Rodrigues
    Rosa, Daniela Dornelles
    Maia, Ana Luiza
    Goemann, Iuri Martin
    CLINICAL BREAST CANCER, 2022, 22 (05) : 418 - 423
  • [43] Metastatic Pattern of Breast Cancer by Histologic Grade: A SEER Population-based Study
    Gao, Chaowei
    Wang, Jiangen
    He, Peisheng
    Xiong, Xin
    DISCOVERY MEDICINE, 2022, 34 (173) : 189 - 197
  • [44] Impact of neoadjuvant compared to adjuvant chemotherapy on prognosis in patients with hormone-receptor positive / HER2-negative breast cancer: A propensity score matching population-based study
    Hosseini-Mellner, Servah
    Wickberg, Asa
    Karakatsanis, Andreas
    Valachis, Antonis
    BREAST, 2024, 76
  • [45] Trends in endocrine therapy prescription and survival in patients with non-metastatic hormone receptor positive breast cancer treated with endocrine therapy: A population based-study
    Kamga, Ariane Mamguem
    Billa, Oumar
    Ladoire, Sylvain
    Poillot, Marie-Laure
    Jolimoy, Genevieve
    Roignot, Patrick
    Coutant, Charles
    Desmoulins, Isabelle
    Maynadie, Marc
    Dabakuyo-Yonli, Tienhan Sandrine
    BREAST, 2021, 59 : 79 - 86
  • [46] Increased mortality in HER2 positive, oestrogen receptor positive invasive breast cancer: a population-based study
    C A Purdie
    L Baker
    A Ashfield
    S Chatterjee
    L B Jordan
    P Quinlan
    D J A Adamson
    J A Dewar
    A M Thompson
    British Journal of Cancer, 2010, 103 : 475 - 481
  • [47] Increased mortality in HER2 positive, oestrogen receptor positive invasive breast cancer: a population-based study
    Purdie, C. A.
    Baker, L.
    Ashfield, A.
    Chatterjee, S.
    Jordan, L. B.
    Quinlan, P.
    Adamson, D. J. A.
    Dewar, J. A.
    Thompson, A. M.
    BRITISH JOURNAL OF CANCER, 2010, 103 (04) : 475 - 481
  • [48] Association of Endocrine Therapy with Survival for Patients with Small, Hormone Receptor-Positive, HER2-Negative, Breast Cancer
    Ma, S. J.
    Oladeru, O. T.
    Sood, A. J.
    Mikucki, M.
    Farrugia, M. K.
    Singh, A. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E74 - E74
  • [49] Prognostic disparities in young patients based on breast cancer subtype: A population-based study from the SEER database
    Chen, Bing
    Zhang, Xiaojuan
    Liu, Yi
    Wang, Chuandong
    MEDICINE, 2023, 102 (13) : E33416
  • [50] HER2 testing in a population-based study of patients with metastatic breast cancer treated with trastuzumab
    O'Malley, Frances P.
    Thomson, Tom
    Julian, Jim
    Have, Cherry
    Crosby, Roxanne
    Gelmon, Karen
    Andrulis, Irene
    Whelan, Tim
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2008, 132 (01) : 61 - 65
12345